Title: Depot medroxy progesterone acetate (DMPA): Its acceptance, compliance and factors influencing continuation rates among women attending Lal Ded Hospital in Kashmir
Authors: Dr Fariha Aman, Dr Sami Seema
DOI: https://dx.doi.org/10.18535/jmscr/v7i12.56
Abstract
Background: The unmet needs for contraception in our country is about 13%.Therefore in order to achieve a good community health and to reduce the unwanted pregnancy rates a good contraceptive advice is the need of hour.
Methods: The present study was a longitudinal hospital based study which was conducted at Lal Ded Hospital, an associated hospital of Government Medical College Srinagar with an aim to estimate the acceptance, compliance and factors influencing continuation rates of Depot medroxy progesterone acetate among women attending Lal Ded Hospital in Kashmir for contraceptive advices. The study was conducted over the time period of 15 months. Meticulous follow up was kept for all the women recruited in the study.
Results: The study concluded that depot medroxy progesterone acetate is highly effective contraceptive with low failure rate, and high acceptability when women are effectively counselled. Also, it should be made freely and easily available through health care facilities.
Conclusions: It should be available as a first line method to all who wish to opt for reversible methods of contraceptive.
Keywords: Antara, Acceptance, Contraceptive, Counselling, DMPA.
References
- Chaurasia Aalok Ranjan SR. 40years of planned family planning efforts in India. Int.Union Sci Study popul (Internet) 2017.
- Saroha E, Altarac M, Sibley LM. Low use of contraceptives among rural women in Maitha,Uttar Pradesh, India. J Indian Med Assoc. 2013;111(5):302-6.
- Ali MM, Cleland J, Shah IH. Causes and consequences of contraceptive discontinuation: Evidence from 60 demographic and health surveys. World Health Organization; 2012.
- Blanc AK, Curtis SL, Croft TN. Monitoring contraceptive continuation: links to fertility outcomes and quality of care. Stud Fam Plann 2002;33(2):127–4.
- Spieler J. Sayana® press: can it be a “game changer” for reducing unmet need for family planning? Contraception 2014;89 (5):335–86.
- Medical eligibility criteria for contraceptive use. 4th end, 2009.
- Cameron ST, Glasier A, Johnstone A. Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception. Contraception 2012;85(5):458–64.
- Cover J, Namagembe A, Tumusiime J, Nsangi D, Lim J, Nakiganda-Busiku D. Continuation of injectable contraception when self-injected vs. administered by a facility based health worker: A non-randomized, prospective cohort study in Uganda. Contraception 2018;98:383–8.
- Burke HM, Chen M, Buluzi M, Fuchs R, Wevill S, Venkatasubramanian L, et al. Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial. Lancet Glob Health 2018;6(5):e568–78.
- Bitzer J, Gemzell-Danielsson K, Roumen F, Marintcheva-petrova-M, Van Bakel B, Oddens BJ. The CHOICE study: effect of counselling on the selection of combined hormonal contraceptive methods in 11 countries. Eur J Contracept Reprod Health Care 2012;17:65-78.
- Baumgartner JN, Morroni C, Mlobeli RD, Otterness C, Buga G, Chen M. Impact of a provider job aid intervention on injectable contraceptive continuation in South Africa. Stud Fam Plann 2012;43(4):305–14.
- Lei Z-W, Wu SC, Garceau RJ, Jiang S, Yang Q-Z, Wang W-L, et al. Effect of pretreatment counseling on discontinuation rates in Chinese women given depomedroxy progesterone acetate for contraception. Contraception 1996;53 (6):357–61.
- Cetina TECD, Canto P, Luna MO. Effect of counseling to improve compliance in Mexican women receiving depot-medroxy progesterone acetate. Contraception 2001;63Vl(3):143–6